No connection

Search Results

AMZN vs PASW

AMZN
Amazon.com, Inc.
BULLISH
Price
$221.25
Market Cap
$2.38T
Sector
Consumer Cyclical
AI Confidence
82%
PASW
Ping An Biomedical Co., Ltd.
BEARISH
Price
$0.17
Market Cap
$20.7M
Sector
Consumer Cyclical
AI Confidence
90%

Valuation

P/E Ratio
AMZN
29.86
PASW
--
Forward P/E
AMZN
23.55
PASW
--
P/B Ratio
AMZN
5.78
PASW
0.51
P/S Ratio
AMZN
3.31
PASW
0.61
EV/EBITDA
AMZN
16.68
PASW
-0.91

Profitability

Gross Margin
AMZN
50.29%
PASW
2.78%
Operating Margin
AMZN
10.53%
PASW
-69.64%
Profit Margin
AMZN
10.83%
PASW
-37.57%
ROE
AMZN
22.29%
PASW
-67.43%
ROA
AMZN
6.93%
PASW
-14.67%

Growth

Revenue Growth
AMZN
13.6%
PASW
-62.0%
Earnings Growth
AMZN
5.0%
PASW
--

Financial Health

Debt/Equity
AMZN
0.43
PASW
0.23
Current Ratio
AMZN
1.05
PASW
2.76
Quick Ratio
AMZN
0.84
PASW
0.8

Dividends

Dividend Yield
AMZN
--
PASW
--
Payout Ratio
AMZN
0.0%
PASW
0.0%

AI Verdict

AMZN BULLISH

Amazon exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and a healthy Debt/Equity ratio of 0.43. While the current price of $221.25 represents a significant premium over the Graham Number ($79.92) and Intrinsic Value ($107.45), this is typical for a high-growth dominant player in the internet retail and cloud space. Strong revenue growth (13.6%) and a superior ROE (22.29%) compared to the sector average (4.42%) justify the valuation premium. Despite bearish insider selling, the strong analyst consensus and consistent earnings beat history support a positive long-term outlook.

Strengths
Strong revenue growth of 13.6% YoY, outperforming sector average
Exceptional ROE of 22.29% compared to sector average of 4.42%
Conservative leverage with a Debt/Equity ratio of 0.43
Risks
Significant valuation gap between current price and deterministic intrinsic value
Bearish insider sentiment with consistent selling by the CEO and officers
Tight liquidity indicated by a Current Ratio of 1.05 and Quick Ratio of 0.84
PASW BEARISH

PASW presents a classic 'value trap' scenario, characterized by a stable Piotroski F-Score of 5/9 but catastrophic operational decay. While the balance sheet remains relatively clean with low debt and a healthy current ratio, the company has suffered a massive 62% year-over-year revenue collapse and negative profit margins. The 95% decline in share price over the last year reflects a fundamental breakdown in the business model, which is not offset by the low Price-to-Book ratio of 0.51.

Strengths
Low Debt/Equity ratio (0.23) indicating minimal leverage
Strong Current Ratio (2.76) suggesting short-term liquidity
Trading significantly below book value (P/B 0.51)
Risks
Severe revenue contraction (-62% YoY)
Extremely thin gross margins (2.78%) leaving no room for error
Deeply negative operating margins (-69.64%)

Compare Another Pair

AMZN vs PASW: Head-to-Head Comparison

This page compares Amazon.com, Inc. (AMZN) and Ping An Biomedical Co., Ltd. (PASW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile